More articles from psychopharmacology for the clinician

You have access
Therapeutic abstention in the treatment of depression in first-episode psychosis
Priyadharshini Sabesan and Lena Palaniyappan

J Psychiatry Neurosci November 01, 2020 45 (6) 441-442; DOI: https://doi.org/10.1503/jpn.200059
You have access
Treating anxious syndromes with pregabalin in patients with psychosis
Nicolas Garel, David Bloom and Ridha Joober

J Psychiatry Neurosci September 01, 2020 45 (5) 370; DOI: https://doi.org/10.1503/jpn.200033
You have access
Long-acting injectable antipsychotics: choosing the right dose
David Carlone and Nicholas Delva

J Psychiatry Neurosci July 01, 2020 45 (4) 298; DOI: https://doi.org/10.1503/jpn.200015
You have access
Consensus statement on the use of clozapine during the COVID-19 pandemic
Dan Siskind, William G. Honer, Scott Clark, Christoph U. Correll, Alkomiet Hasan, Oliver Howes, John M. Kane, Deanna L. Kelly, Robert Laitman, Jimmy Lee, James H. MacCabe, Nick Myles, Jimmi Nielsen, Peter F. Schulte, David Taylor, Helene Verdoux, Amanda Wheeler and Oliver Freudenreich

J Psychiatry Neurosci May 01, 2020 45 (3) 222-223; DOI: https://doi.org/10.1503/jpn.200061
You have access
Mu-opioid antagonism in the treatment of cannabis use disorder
Oussama Kebir, Xavier Laqueille and Fayçal Mouaffak

J Psychiatry Neurosci March 01, 2020 45 (2) 143-144; DOI: https://doi.org/10.1503/jpn.190182
You have access
Kleptomania treated with naltrexone in a patient with intellectual disability
Faycal Mouaffak, Sonia Hamzaoui, Oussama Kebir and Xavier Laqueille

J Psychiatry Neurosci January 01, 2020 45 (1) 71-72; DOI: https://doi.org/10.1503/jpn.190064
You have access
Treatment of first-episode psychosis in patients with autism-spectrum disorder and intellectual deficiency
Nicolas Garel and Ridha Joober

J Psychiatry Neurosci November 01, 2019 44 (6) E31-E32; DOI: https://doi.org/10.1503/jpn.190081
You have access
Management of sexual adverse effects induced by atypical antipsychotic medication
Laura Downing, David D. Kim, Ric M. Procyshyn and Philip Tibbo

J Psychiatry Neurosci July 01, 2019 44 (4) 287-288; DOI: https://doi.org/10.1503/jpn.190053
You have access
N-Acetylcysteine augmentation in refractory obsessive–compulsive disorder
Sreenivasa Bhaskara

J Psychiatry Neurosci May 01, 2019 44 (3) 215-216; DOI: https://doi.org/10.1503/jpn.180179
You have access
Treating resistant depression with 2 forms of convulsive therapy: a clinical case study
Anastasios A. Daskalakis and Zafiris J. Daskalakis

J Psychiatry Neurosci March 01, 2019 44 (2) 143-144; DOI: https://doi.org/10.1503/jpn.180141

Main menu

User menu

Search

More articles from psychopharmacology for the clinician

Pages

Content

Authors & Reviewers

About